2020
DOI: 10.1016/s0959-8049(20)30648-1
|View full text |Cite
|
Sign up to set email alerts
|

Did the BOOG 2013–08, which examines the value of omission of the sentinel lymph node in cT1-2 breast cancer treated with BCT, induce a change in axillary staging and treatment?

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles